Top Headlines

Marketing CBD is mostly about risk tolerance, legal expert says

Marketing CBD is mostly about risk tolerance, legal expert says

The source of CBD should be of concern for the companies marketing the ingredient, said a legal expert at a recent dietary supplement industry event. But he also said the regulatory landscape for the ingredient is shifting so fast that any opinions he...

Global Industry News

News

Trends

Spotlight

Research backs personalized nutrition process, even if data on customized products lacks, expert says Research backs personalized nutrition process, even if data on customized products lacks, expert says © Getty Images / gonin Study unlocks potential anti-inflammatory action of ETA omega-3 Marketing CBD is mostly about risk tolerance, legal expert says Marketing CBD is mostly about risk tolerance, legal expert says Getty Images / Halfpoint Researchers take a closer look at which polyphenols may slash cardiovascular disease risk Getty Images More brands seeking to root out inflammation in healthy aging sphere Amarin sues two omega-3s manufacturers, alleging they used company's drug trial to market supplements Amarin sues two omega-3s manufacturers, alleging they used company's drug trial to market supplements Cypress Systems markets SelenoExcell, a form of selenium bound to yeast. Cypress Systems photo. Cypress Systems to sound out market on how best to support use of clinically validated ingredients Focus on functional sports benefits seen as growing opportunity within microbiome research Focus on functional sports benefits seen as growing opportunity within microbiome research © Getty Images / Obencem Prebiotic combination shows metabolic benefits for adults with acne: Pilot data What is CBD being marketed for? Proponents seem deliberately vague on claims What is CBD being marketed for? Proponents seem deliberately vague on claims

Follow us

Featured Events

View more

Products

View more

Webinars

On-demand webinars

Featured Suppliers

All suppliers